1.
Rageth CJ,
O’Flynn EA,
Comstock C,
Kurtz C,
Kubik R,
Madjar H,
Lepori D,
Kampmann G,
Mundinger A,
Baege A,
Decker T,
Hosch S,
Tausch C,
Delaloye JF,
Morris E,
Varga Z.
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Breast Cancer Res Treat.
2016;159:1–11.
2.
Strachan C,
Horgan K,
Millican-Slater RA,
Shaaban AM,
Sharma N,
to Strachan CC.
Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice? J Clin Pathol.
2016;69:248–254.
3.
Bianchi S,
Caumo F,
Della Libera D,
Frigerio A,
Morrone D,
Pietribiasi F,
Paduos A,
Ponti A,
Rizzo A,
Saguatti G.
Documento di consenso sulle procedure diagnostiche preoperatorie nelle lesioni mammarie.
Available from: http://www.senonetwork.it/app/public/files/download/percorso-diagnostico-preoperatorio-GISMA-B3_yshwu84f.pdf
4.
Rakha EA,
Lee AHS,
Jenkins JA,
Murphy AE,
Hamilton LJ,
Ellis IO.
Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
Int J Cancer.
2011;129:1417–1424.
5.
Lee AHS,
Denley HE,
Pinder SE,
Ellis IO,
Elston CW,
Vujovic P,
Macmillan RD,
Evans AJ.
Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
Histopathology.
2003;42:331–336.
6.
Houssami N,
Ciatto S,
Bilous M,
Vezzosi V,
Bianchi S.
Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3).
Br J Cancer.
2007;96:1253–7.
7.
Dillon MF,
McDermott EW,
Hill AD,
O’Doherty A,
O’Higgins N,
Quinn CM.
Predictive value of breast lesions of “uncertain malignant potential” and “suspicious for malignancy” determined by needle core biopsy.
Ann Surg Oncol.
2007;14:704–711.
8.
MacLean GM,
Courtney SP,
Umeh H,
Sanjeev S,
McCormick C,
Smith BM.
Is mode of presentation of B3 breast core biopsies (screen-detected or symptomatic) a distinguishing factor in the final histopathologic result or risk of diagnosis of malignancy? World J Surg.
2013;37:2607–2612.